$ILIU Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INTERLEUKIN GENETICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in INTERLEUKIN GENETICS INC. Get notifications about new insider transactions in INTERLEUKIN GENETICS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 12 2017 | ILIU | INTERLEUKIN GENETI ... | Toutain Stephan | Chief Commercial Of ... | Option Exercise | A | 0.10 | 182,547 | 17,342 | 182,547 | |
Jan 26 2017 | ILIU | INTERLEUKIN GENETI ... | KORNMAN KENNETH S | President and CSO | Option Exercise | A | 0.12 | 3,625,746 | 448,505 | 3,625,746 | |
Jan 26 2017 | ILIU | INTERLEUKIN GENETI ... | Carbeau Mark B | CEO | Option Exercise | A | 0.12 | 1,278,653 | 158,169 | 1,278,653 | |
Jan 26 2017 | ILIU | INTERLEUKIN GENETI ... | WEAVER JAMES M | Director | Option Exercise | A | 0.12 | 168,450 | 20,837 | 168,450 | |
Jan 26 2017 | ILIU | INTERLEUKIN GENETI ... | Mills William C. III | Director | Option Exercise | A | 0.12 | 168,450 | 20,837 | 168,450 | |
Jan 26 2017 | ILIU | INTERLEUKIN GENETI ... | Toutain Stephan | Chief Commercial Of ... | Option Exercise | A | 0.12 | 365,093 | 45,162 | 365,093 | |
Oct 21 2016 | ILIU | INTERLEUKIN GENETI ... | Carbeau Mark B | CEO | Option Exercise | A | 0.18 | 5,000,000 | 877,000 | 5,000,000 | |
Oct 21 2016 | ILIU | INTERLEUKIN GENETI ... | Toutain Stephan | Chief Commercial Of ... | Option Exercise | A | 0.18 | 3,738,933 | 655,809 | 3,738,933 | |
Aug 03 2016 | ILIU | INTERLEUKIN GENETI ... | PYXIS INNOVATIONS INC | 10% Owner | Option Exercise | P | 0.10 | 5,030,181 | 500,000 | 5,030,181 | |
Aug 03 2016 | ILIU | INTERLEUKIN GENETI ... | PYXIS INNOVATIONS INC | 10% Owner | Buy | P | 0.10 | 5,030,181 | 500,000 | 42,595,659 | 37.6 M to 42.6 M (+13.39 %) |
Aug 02 2016 | ILIU | INTERLEUKIN GENETI ... | BASKETT FOREST | 10% Owner | Option Exercise | P | 0.10 | 20,120,724 | 2,000,000 | 20,120,724 | |
Aug 02 2016 | ILIU | INTERLEUKIN GENETI ... | BASKETT FOREST | 10% Owner | Buy | P | 0.10 | 20,120,724 | 2,000,000 | 55,418,811 | 35.3 M to 55.4 M (+57.00 %) |
Aug 02 2016 | ILIU | INTERLEUKIN GENETI ... | Weller Harry R | 10% Owner | Option Exercise | P | 0.10 | 20,120,724 | 2,000,000 | 20,120,724 | |
Aug 02 2016 | ILIU | INTERLEUKIN GENETI ... | Weller Harry R | 10% Owner | Buy | P | 0.10 | 20,120,724 | 2,000,000 | 55,418,811 | 35.3 M to 55.4 M (+57.00 %) |
Aug 02 2016 | ILIU | INTERLEUKIN GENETI ... | Viswanathan Ravi | 10% Owner | Option Exercise | P | 0.10 | 20,120,724 | 2,000,000 | 20,120,724 | |
Aug 02 2016 | ILIU | INTERLEUKIN GENETI ... | Viswanathan Ravi | 10% Owner | Buy | P | 0.10 | 20,120,724 | 2,000,000 | 55,418,811 | 35.3 M to 55.4 M (+57.00 %) |
Aug 02 2016 | ILIU | INTERLEUKIN GENETI ... | Sonsini Peter W. | 10% Owner | Option Exercise | P | 0.10 | 20,120,724 | 2,000,000 | 20,120,724 | |
Aug 02 2016 | ILIU | INTERLEUKIN GENETI ... | Sonsini Peter W. | 10% Owner | Buy | P | 0.10 | 20,120,724 | 2,000,000 | 55,418,811 | 35.3 M to 55.4 M (+57.00 %) |
Aug 02 2016 | ILIU | INTERLEUKIN GENETI ... | SANDELL SCOTT D | 10% Owner | Option Exercise | P | 0.10 | 20,120,724 | 2,000,000 | 20,120,724 | |
Aug 02 2016 | ILIU | INTERLEUKIN GENETI ... | SANDELL SCOTT D | 10% Owner | Buy | P | 0.10 | 20,120,724 | 2,000,000 | 55,418,811 | 35.3 M to 55.4 M (+57.00 %) |
Aug 02 2016 | ILIU | INTERLEUKIN GENETI ... | MOTT DAVID M | 10% Owner | Option Exercise | P | 0.10 | 20,120,724 | 2,000,000 | 20,120,724 | |
Aug 02 2016 | ILIU | INTERLEUKIN GENETI ... | MOTT DAVID M | 10% Owner | Buy | P | 0.10 | 20,120,724 | 2,000,000 | 55,418,811 | 35.3 M to 55.4 M (+57.00 %) |
Aug 02 2016 | ILIU | INTERLEUKIN GENETI ... | KOLLURI KRISHNA KITTU | 10% Owner | Option Exercise | P | 0.10 | 20,120,724 | 2,000,000 | 20,120,724 | |
Aug 02 2016 | ILIU | INTERLEUKIN GENETI ... | KOLLURI KRISHNA KITTU | 10% Owner | Buy | P | 0.10 | 20,120,724 | 2,000,000 | 55,418,811 | 35.3 M to 55.4 M (+57.00 %) |
Aug 02 2016 | ILIU | INTERLEUKIN GENETI ... | KERINS PATRICK J | 10% Owner | Option Exercise | P | 0.10 | 20,120,724 | 2,000,000 | 20,120,724 | |
Aug 02 2016 | ILIU | INTERLEUKIN GENETI ... | KERINS PATRICK J | 10% Owner | Buy | P | 0.10 | 20,120,724 | 2,000,000 | 55,418,811 | 35.3 M to 55.4 M (+57.00 %) |
Aug 02 2016 | ILIU | INTERLEUKIN GENETI ... | Florence Anthony A. Jr. | 10% Owner | Option Exercise | P | 0.10 | 20,120,724 | 2,000,000 | 20,120,724 | |
Aug 02 2016 | ILIU | INTERLEUKIN GENETI ... | Florence Anthony A. Jr. | 10% Owner | Buy | P | 0.10 | 20,120,724 | 2,000,000 | 55,418,811 | 35.3 M to 55.4 M (+57.00 %) |
Aug 02 2016 | ILIU | INTERLEUKIN GENETI ... | BARRIS PETER J | 10% Owner | Option Exercise | P | 0.10 | 20,120,724 | 2,000,000 | 20,120,724 | |
Aug 02 2016 | ILIU | INTERLEUKIN GENETI ... | BARRIS PETER J | 10% Owner | Buy | P | 0.10 | 20,120,724 | 2,000,000 | 55,418,811 | 35.3 M to 55.4 M (+57.00 %) |
Aug 02 2016 | ILIU | INTERLEUKIN GENETI ... | BARRETT M JAMES | 10% Owner | Option Exercise | P | 0.10 | 20,120,724 | 2,000,000 | 20,120,724 | |
Aug 02 2016 | ILIU | INTERLEUKIN GENETI ... | BARRETT M JAMES | 10% Owner | Buy | P | 0.10 | 20,120,724 | 2,000,000 | 55,418,811 | 35.3 M to 55.4 M (+57.00 %) |
Aug 02 2016 | ILIU | INTERLEUKIN GENETI ... | Growth Equity Opportunities Fu ... | 10% Owner | Option Exercise | P | 0.10 | 20,120,724 | 2,000,000 | 20,120,724 | |
Aug 02 2016 | ILIU | INTERLEUKIN GENETI ... | Growth Equity Opportunities Fu ... | 10% Owner | Buy | P | 0.10 | 20,120,724 | 2,000,000 | 55,418,811 | 35.3 M to 55.4 M (+57.00 %) |
Aug 02 2016 | ILIU | INTERLEUKIN GENETI ... | BAY CITY CAPITAL LLC | 10% Owner | Option Exercise | P | 0.10 | 564,386 | 56,100 | 564,386 | |
Aug 02 2016 | ILIU | INTERLEUKIN GENETI ... | BAY CITY CAPITAL LLC | 10% Owner | Option Exercise | P | 0.10 | 29,616,700 | 2,943,900 | 29,616,700 | |
Aug 02 2016 | ILIU | INTERLEUKIN GENETI ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 0.10 | 564,386 | 56,100 | 1,444,485 | 880.1 K to 1.4 M (+64.13 %) |
Aug 02 2016 | ILIU | INTERLEUKIN GENETI ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 0.10 | 29,616,700 | 2,943,900 | 75,800,716 | 46.2 M to 75.8 M (+64.13 %) |
Aug 01 2016 | ILIU | INTERLEUKIN GENETI ... | WEAVER JAMES M | Director | Option Exercise | P | 0.10 | 100,603 | 10,000 | 100,603 | |
Aug 01 2016 | ILIU | INTERLEUKIN GENETI ... | WEAVER JAMES M | Director | Buy | P | 0.10 | 100,603 | 10,000 | 100,603 | 0 to 100.6 K |
Aug 01 2016 | ILIU | INTERLEUKIN GENETI ... | KORNMAN KENNETH S | President and CSO | Option Exercise | P | 0.10 | 25,150 | 2,500 | 25,150 | |
Aug 01 2016 | ILIU | INTERLEUKIN GENETI ... | KORNMAN KENNETH S | President and CSO | Buy | P | 0.10 | 25,150 | 2,500 | 400,065 | 374.9 K to 400.1 K (+6.71 %) |
Aug 01 2016 | ILIU | INTERLEUKIN GENETI ... | DiPalma Stephen J. | Interim CFO | Option Exercise | P | 0.10 | 100,603 | 10,000 | 100,603 | |
Aug 01 2016 | ILIU | INTERLEUKIN GENETI ... | DiPalma Stephen J. | Interim CFO | Buy | P | 0.10 | 100,603 | 10,000 | 349,855 | 249.3 K to 349.9 K (+40.36 %) |
Aug 01 2016 | ILIU | INTERLEUKIN GENETI ... | Carbeau Mark B | Chief Executive Off ... | Option Exercise | P | 0.10 | 100,603 | 10,000 | 100,603 | |
Aug 01 2016 | ILIU | INTERLEUKIN GENETI ... | Carbeau Mark B | Chief Executive Off ... | Buy | P | 0.10 | 100,603 | 10,000 | 100,603 | 0 to 100.6 K |
Jan 29 2016 | ILIU | INTERLEUKIN GENETI ... | WEAVER JAMES M | Director | Option Exercise | A | 0.05 | 125,000 | 6,250 | 125,000 | |
Jan 28 2016 | ILIU | INTERLEUKIN GENETI ... | Mills William C. III | Director | Option Exercise | A | 0.05 | 100,000 | 5,000 | 100,000 | |
Jan 28 2016 | ILIU | INTERLEUKIN GENETI ... | KORNMAN KENNETH S | President and CSO | Option Exercise | A | 0.05 | 400,000 | 20,000 | 400,000 | |
Dec 15 2015 | ILIU | INTERLEUKIN GENETI ... | KORNMAN KENNETH S | President and CSO | Option Exercise | A | 0.07 | 400,000 | 28,000 | 400,000 | |
Apr 08 2015 | ILIU | INTERLEUKIN GENETI ... | Carbeau Mark B | Chief Executive Off ... | Option Exercise | A | 0.15 | 14,245,227 | 2,172,397 | 14,245,227 | |
Jan 26 2015 | ILIU | INTERLEUKIN GENETI ... | KORNMAN KENNETH S | See Remarks | Option Exercise | A | 0.26 | 2,030,000 | 527,800 | 2,030,000 | |
Jan 26 2015 | ILIU | INTERLEUKIN GENETI ... | Snyder Scott A. | Chief Marketing Off ... | Option Exercise | A | 0.26 | 660,000 | 171,600 | 660,000 | |
Dec 30 2014 | ILIU | INTERLEUKIN GENETI ... | DiPalma Stephen J. | Interim CFO | Option Exercise | P | 0.10 | 249,252 | 25,000 | 249,252 | |
Dec 30 2014 | ILIU | INTERLEUKIN GENETI ... | DiPalma Stephen J. | Interim CFO | Buy | P | 0.10 | 249,252 | 25,000 | 249,252 | 0 to 249.3 K |
Dec 29 2014 | ILIU | INTERLEUKIN GENETI ... | BARRETT M JAMES | 10% Owner | Option Exercise | P | 0.10 | 19,868,965 | 1,992,857 | 19,868,965 | |
Dec 29 2014 | ILIU | INTERLEUKIN GENETI ... | BARRETT M JAMES | 10% Owner | Buy | P | 0.10 | 19,868,965 | 1,992,857 | 35,298,087 | 15.4 M to 35.3 M (+128.78 %) |
Dec 29 2014 | ILIU | INTERLEUKIN GENETI ... | BARRIS PETER J | 10% Owner | Option Exercise | P | 0.10 | 19,868,965 | 1,992,857 | 19,868,965 | |
Dec 29 2014 | ILIU | INTERLEUKIN GENETI ... | BARRIS PETER J | 10% Owner | Buy | P | 0.10 | 19,868,965 | 1,992,857 | 35,298,087 | 15.4 M to 35.3 M (+128.78 %) |
Dec 29 2014 | ILIU | INTERLEUKIN GENETI ... | BASKETT FOREST | 10% Owner | Option Exercise | P | 0.10 | 19,868,965 | 1,992,857 | 19,868,965 | |
Dec 29 2014 | ILIU | INTERLEUKIN GENETI ... | BASKETT FOREST | 10% Owner | Buy | P | 0.10 | 19,868,965 | 1,992,857 | 35,298,087 | 15.4 M to 35.3 M (+128.78 %) |
Dec 29 2014 | ILIU | INTERLEUKIN GENETI ... | DRANT RYAN D | 10% Owner | Option Exercise | P | 0.10 | 19,868,965 | 1,992,857 | 19,868,965 | |
Dec 29 2014 | ILIU | INTERLEUKIN GENETI ... | DRANT RYAN D | 10% Owner | Buy | P | 0.10 | 19,868,965 | 1,992,857 | 35,298,087 | 15.4 M to 35.3 M (+128.78 %) |
Dec 29 2014 | ILIU | INTERLEUKIN GENETI ... | Florence Anthony A. Jr. | 10% Owner | Option Exercise | P | 0.10 | 19,868,965 | 1,992,857 | 19,868,965 | |
Dec 29 2014 | ILIU | INTERLEUKIN GENETI ... | Florence Anthony A. Jr. | 10% Owner | Buy | P | 0.10 | 19,868,965 | 1,992,857 | 35,298,087 | 15.4 M to 35.3 M (+128.78 %) |
Dec 29 2014 | ILIU | INTERLEUKIN GENETI ... | KERINS PATRICK J | 10% Owner | Option Exercise | P | 0.10 | 19,868,965 | 1,992,857 | 19,868,965 | |
Dec 29 2014 | ILIU | INTERLEUKIN GENETI ... | KERINS PATRICK J | 10% Owner | Buy | P | 0.10 | 19,868,965 | 1,992,857 | 35,298,087 | 15.4 M to 35.3 M (+128.78 %) |
Dec 29 2014 | ILIU | INTERLEUKIN GENETI ... | KOLLURI KRISHNA KITTU | 10% Owner | Option Exercise | P | 0.10 | 19,868,965 | 1,992,857 | 19,868,965 | |
Dec 29 2014 | ILIU | INTERLEUKIN GENETI ... | KOLLURI KRISHNA KITTU | 10% Owner | Buy | P | 0.10 | 19,868,965 | 1,992,857 | 35,298,087 | 15.4 M to 35.3 M (+128.78 %) |
Dec 29 2014 | ILIU | INTERLEUKIN GENETI ... | MOTT DAVID M | 10% Owner | Option Exercise | P | 0.10 | 19,868,965 | 1,992,857 | 19,868,965 | |
Dec 29 2014 | ILIU | INTERLEUKIN GENETI ... | MOTT DAVID M | 10% Owner | Buy | P | 0.10 | 19,868,965 | 1,992,857 | 35,298,087 | 15.4 M to 35.3 M (+128.78 %) |
Dec 29 2014 | ILIU | INTERLEUKIN GENETI ... | SANDELL SCOTT D | 10% Owner | Option Exercise | P | 0.10 | 19,868,965 | 1,992,857 | 19,868,965 | |
Dec 29 2014 | ILIU | INTERLEUKIN GENETI ... | SANDELL SCOTT D | 10% Owner | Buy | P | 0.10 | 19,868,965 | 1,992,857 | 35,298,087 | 15.4 M to 35.3 M (+128.78 %) |
Dec 29 2014 | ILIU | INTERLEUKIN GENETI ... | Sonsini Peter W. | 10% Owner | Option Exercise | P | 0.10 | 19,868,965 | 1,992,857 | 19,868,965 | |
Dec 29 2014 | ILIU | INTERLEUKIN GENETI ... | Sonsini Peter W. | 10% Owner | Buy | P | 0.10 | 19,868,965 | 1,992,857 | 35,298,087 | 15.4 M to 35.3 M (+128.78 %) |
Dec 29 2014 | ILIU | INTERLEUKIN GENETI ... | Viswanathan Ravi | 10% Owner | Option Exercise | P | 0.10 | 19,868,965 | 1,992,857 | 19,868,965 | |
Dec 29 2014 | ILIU | INTERLEUKIN GENETI ... | Viswanathan Ravi | 10% Owner | Buy | P | 0.10 | 19,868,965 | 1,992,857 | 35,298,087 | 15.4 M to 35.3 M (+128.78 %) |
Dec 29 2014 | ILIU | INTERLEUKIN GENETI ... | Weller Harry R | 10% Owner | Option Exercise | P | 0.10 | 19,868,965 | 1,992,857 | 19,868,965 | |
Dec 29 2014 | ILIU | INTERLEUKIN GENETI ... | Weller Harry R | 10% Owner | Buy | P | 0.10 | 19,868,965 | 1,992,857 | 35,298,087 | 15.4 M to 35.3 M (+128.78 %) |
Dec 29 2014 | ILIU | INTERLEUKIN GENETI ... | Growth Equity Opportunities Fu ... | 10% Owner | Option Exercise | P | 0.10 | 19,868,965 | 1,992,857 | 19,868,965 | |
Dec 29 2014 | ILIU | INTERLEUKIN GENETI ... | Growth Equity Opportunities Fu ... | 10% Owner | Buy | P | 0.10 | 19,868,965 | 1,992,857 | 35,298,087 | 15.4 M to 35.3 M (+128.78 %) |
Dec 24 2014 | ILIU | INTERLEUKIN GENETI ... | BAY CITY CAPITAL LLC | 10% Owner | Option Exercise | P | 0.10 | 495,400 | 49,689 | 495,400 | |
Dec 24 2014 | ILIU | INTERLEUKIN GENETI ... | BAY CITY CAPITAL LLC | 10% Owner | Option Exercise | P | 0.10 | 25,996,552 | 2,607,454 | 25,996,552 | |
Dec 24 2014 | ILIU | INTERLEUKIN GENETI ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 0.10 | 495,400 | 49,689 | 880,099 | 384.7 K to 880.1 K (+128.78 %) |
Dec 24 2014 | ILIU | INTERLEUKIN GENETI ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 0.10 | 25,996,552 | 2,607,454 | 46,184,016 | 20.2 M to 46.2 M (+128.78 %) |
Apr 04 2014 | ILIU | INTERLEUKIN GENETI ... | WEAVER JAMES M | Director | Option Exercise | A | 0.35 | 125,000 | 43,750 | 125,000 | |
Oct 24 2013 | ILIU | INTERLEUKIN GENETI ... | Mills William C. III | Director | Option Exercise | A | 0.38 | 85,000 | 32,292 | 85,000 | |
Oct 24 2013 | ILIU | INTERLEUKIN GENETI ... | Snyder Scott A. | Chief Marketing Off ... | Option Exercise | A | 0.38 | 675,000 | 256,433 | 675,000 | |
Oct 24 2013 | ILIU | INTERLEUKIN GENETI ... | Lurier Eliot M | Chief Financial Off ... | Option Exercise | A | 0.38 | 750,000 | 284,925 | 750,000 | |
Oct 24 2013 | ILIU | INTERLEUKIN GENETI ... | KORNMAN KENNETH S | See Remarks | Option Exercise | A | 0.38 | 2,250,000 | 854,775 | 2,250,000 | |
May 21 2013 | ILIU | INTERLEUKIN GENETI ... | PYXIS INNOVATIONS INC | 10% Owner | Option Exercise | C | 5.68 | 14,316,255 | 81,291,991 | 0 | |
May 21 2013 | ILIU | INTERLEUKIN GENETI ... | PYXIS INNOVATIONS INC | 10% Owner | Option Exercise | C | 0.00 | 5,000,000 | 0 | 0 | |
May 21 2013 | ILIU | INTERLEUKIN GENETI ... | PYXIS INNOVATIONS INC | 10% Owner | Buy | C | 5.68 | 2,521,222 | 14,316,255 | 37,565,478 | 35 M to 37.6 M (+7.19 %) |
May 21 2013 | ILIU | INTERLEUKIN GENETI ... | PYXIS INNOVATIONS INC | 10% Owner | Buy | C | 0.00 | 28,160,200 | 0 | 35,044,256 | 6.9 M to 35 M (+409.06 %) |
May 21 2013 | ILIU | INTERLEUKIN GENETI ... | Delta Dental Plan of Michigan, ... | 10% Owner | Option Exercise | C | 0.27 | 10,928,962 | 3,000,000 | 0 | |
May 21 2013 | ILIU | INTERLEUKIN GENETI ... | Delta Dental Plan of Michigan, ... | 10% Owner | Buy | C | 0.27 | 10,928,961 | 3,000,000 | 10,928,961 | 0 to 10.9 M |
Jan 03 2013 | ILIU | INTERLEUKIN GENETI ... | Snyder Scott A. | Chief Marketing Off ... | Option Exercise | A | 0.29 | 200,000 | 58,000 | 200,000 | |
Dec 21 2012 | ILIU | INTERLEUKIN GENETI ... | Lurier Eliot M | Chief Financial Off ... | Option Exercise | A | 0.34 | 200,000 | 68,000 | 200,000 | |
Dec 21 2012 | ILIU | INTERLEUKIN GENETI ... | KORNMAN KENNETH S | See Remarks | Option Exercise | A | 0.34 | 300,000 | 102,000 | 300,000 | |
Jul 03 2012 | ILIU | INTERLEUKIN GENETI ... | PYXIS INNOVATIONS INC | 10% Owner | Option Exercise | J | 0.32 | 5,000,000 | 1,598,000 | 30,695,245 | |
Jul 03 2012 | ILIU | INTERLEUKIN GENETI ... | PYXIS INNOVATIONS INC | 10% Owner | Option Exercise | J | 0.32 | 5,000,000 | 1,598,000 | 2,535,045 | |
May 09 2011 | ILIU | INTERLEUKIN GENETI ... | KORNMAN KENNETH S | Chief Scientific Of ... | Option Exercise | A | 0.46 | 100,000 | 46,000 | 100,000 | |
Mar 25 2011 | ILIU | INTERLEUKIN GENETI ... | Lurier Eliot M | Chief Financial Off ... | Option Exercise | A | 0.36 | 100,000 | 36,000 | 100,000 | |
Feb 16 2011 | ILIU | INTERLEUKIN GENETI ... | BENDER LEWIS H | Chief Executive Off ... | Option Exercise | A | 0.32 | 500,000 | 160,000 | 500,000 | |
Apr 30 2010 | ILIU | INTERLEUKIN GENETI ... | Mills William C. III | Director | Option Exercise | A | 0.67 | 15,000 | 10,050 | 15,000 | |
Apr 08 2010 | ILIU | INTERLEUKIN GENETI ... | KORNMAN KENNETH S | Chief Scientific Of ... | Option Exercise | A | 0.75 | 30,000 | 22,350 | 30,000 | |
Apr 08 2010 | ILIU | INTERLEUKIN GENETI ... | Lurier Eliot M | Chief Financial Off ... | Option Exercise | A | 0.75 | 60,000 | 44,700 | 60,000 | |
Apr 01 2010 | ILIU | INTERLEUKIN GENETI ... | KORNMAN KENNETH S | Chief Scientific Of ... | Grant | A | 0.75 | 12,500 | 9,375 | 133,750 | 121.3 K to 133.8 K (+10.31 %) |
Mar 19 2010 | ILIU | INTERLEUKIN GENETI ... | CHOWNING MARY E | Director | Option Exercise | A | 0.92 | 15,000 | 13,800 | 15,000 | |
Mar 19 2010 | ILIU | INTERLEUKIN GENETI ... | CHOWNING MARY E | Director | Grant | A | 0.00 | 10,000 | 0 | 30,000 | 20 K to 30 K (+50.00 %) |
Jan 22 2010 | ILIU | INTERLEUKIN GENETI ... | BENDER LEWIS H | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 0.89 | 100,000 | 89,000 | 100,000 | |
Apr 01 2009 | ILIU | INTERLEUKIN GENETI ... | KORNMAN KENNETH S | Chief Scientific Of ... | Grant | A | 0.28 | 12,500 | 3,500 | 121,250 | 108.8 K to 121.3 K (+11.49 %) |
Mar 16 2009 | ILIU | INTERLEUKIN GENETI ... | Lurier Eliot M | Chief Financial Off ... | Option Exercise | A | 0.27 | 30,000 | 8,100 | 30,000 | |
Mar 16 2009 | ILIU | INTERLEUKIN GENETI ... | Lurier Eliot M | Chief Financial Off ... | Grant | A | 0.27 | 16,500 | 4,455 | 26,500 | 10 K to 26.5 K (+165.00 %) |
Mar 16 2009 | ILIU | INTERLEUKIN GENETI ... | BENDER LEWIS H | Chief Executive Off ... | Grant | A | 0.27 | 110,000 | 29,700 | 201,136 | 91.1 K to 201.1 K (+120.70 %) |
Nov 25 2008 | ILIU | INTERLEUKIN GENETI ... | Lurier Eliot M | Chief Financial Off ... | Buy | P | 0.29 | 10,000 | 2,900 | 10,000 | 0 to 10 K |
Nov 24 2008 | ILIU | INTERLEUKIN GENETI ... | BENDER LEWIS H | Chief Executive Off ... | Buy | P | 0.25 | 15,400 | 3,850 | 70,646 | 55.2 K to 70.6 K (+27.88 %) |
Nov 24 2008 | ILIU | INTERLEUKIN GENETI ... | BENDER LEWIS H | Chief Executive Off ... | Buy | P | 0.25 | 4,500 | 1,125 | 55,246 | 50.7 K to 55.2 K (+8.87 %) |
Nov 24 2008 | ILIU | INTERLEUKIN GENETI ... | BENDER LEWIS H | Chief Executive Off ... | Buy | P | 0.24 | 100 | 24 | 50,746 | 50.6 K to 50.7 K (+0.20 %) |
Nov 24 2008 | ILIU | INTERLEUKIN GENETI ... | BENDER LEWIS H | Chief Executive Off ... | Buy | P | 0.27 | 10,000 | 2,700 | 50,646 | 40.6 K to 50.6 K (+24.60 %) |
Nov 24 2008 | ILIU | INTERLEUKIN GENETI ... | CHOWNING MARY E | Director | Buy | P | 0.27 | 5,000 | 1,350 | 20,000 | 15 K to 20 K (+33.33 %) |
Nov 24 2008 | ILIU | INTERLEUKIN GENETI ... | CHOWNING MARY E | Director | Buy | P | 0.25 | 5,000 | 1,250 | 15,000 | 10 K to 15 K (+50.00 %) |
Nov 24 2008 | ILIU | INTERLEUKIN GENETI ... | CHOWNING MARY E | Director | Buy | P | 0.30 | 2,500 | 750 | 10,000 | 7.5 K to 10 K (+33.33 %) |
Nov 24 2008 | ILIU | INTERLEUKIN GENETI ... | CHOWNING MARY E | Director | Buy | P | 0.35 | 5,000 | 1,745 | 7,500 | 2.5 K to 7.5 K (+200.00 %) |
Nov 24 2008 | ILIU | INTERLEUKIN GENETI ... | CHOWNING MARY E | Director | Buy | P | 0.35 | 2,500 | 875 | 2,500 | 0 to 2.5 K |
Nov 20 2008 | ILIU | INTERLEUKIN GENETI ... | BENDER LEWIS H | Chief Executive Off ... | Buy | P | 0.35 | 1,700 | 595 | 40,546 | 38.8 K to 40.5 K (+4.38 %) |
Nov 20 2008 | ILIU | INTERLEUKIN GENETI ... | BENDER LEWIS H | Chief Executive Off ... | Buy | P | 0.33 | 1,765 | 582 | 38,846 | 37.1 K to 38.8 K (+4.76 %) |
Nov 20 2008 | ILIU | INTERLEUKIN GENETI ... | BENDER LEWIS H | Chief Executive Off ... | Buy | P | 0.32 | 8,235 | 2,635 | 37,081 | 28.8 K to 37.1 K (+28.55 %) |
Nov 20 2008 | ILIU | INTERLEUKIN GENETI ... | BENDER LEWIS H | Chief Executive Off ... | Buy | P | 0.50 | 10,000 | 4,980 | 28,846 | 18.8 K to 28.8 K (+53.06 %) |
Nov 20 2008 | ILIU | INTERLEUKIN GENETI ... | BENDER LEWIS H | Chief Executive Off ... | Buy | P | 0.42 | 8,200 | 3,444 | 18,846 | 10.6 K to 18.8 K (+77.02 %) |
Nov 20 2008 | ILIU | INTERLEUKIN GENETI ... | BENDER LEWIS H | Chief Executive Off ... | Buy | P | 0.41 | 100 | 41 | 10,646 | 10.5 K to 10.6 K (+0.95 %) |
Nov 20 2008 | ILIU | INTERLEUKIN GENETI ... | KORNMAN KENNETH S | Pres., and Chief Sc ... | Buy | P | 0.41 | 2,000 | 820 | 108,750 | 106.8 K to 108.8 K (+1.87 %) |
Nov 20 2008 | ILIU | INTERLEUKIN GENETI ... | KORNMAN KENNETH S | Pres., and Chief Sc ... | Buy | P | 0.42 | 1,000 | 420 | 106,750 | 105.8 K to 106.8 K (+0.95 %) |
Nov 20 2008 | ILIU | INTERLEUKIN GENETI ... | KORNMAN KENNETH S | Pres., and Chief Sc ... | Buy | P | 0.47 | 7,000 | 3,290 | 105,750 | 98.8 K to 105.8 K (+7.09 %) |
Nov 14 2008 | ILIU | INTERLEUKIN GENETI ... | KORNMAN KENNETH S | President and Chief ... | Option Exercise | A | 0.48 | 75,000 | 36,000 | 75,000 | |
Jul 28 2008 | ILIU | INTERLEUKIN GENETI ... | CHOWNING MARY E | Director | Option Exercise | A | 1.45 | 15,000 | 21,750 | 15,000 | |
Jun 19 2008 | ILIU | INTERLEUKIN GENETI ... | Lurier Eliot M | Chief Financial Off ... | Option Exercise | A | 1.49 | 40,000 | 59,600 | 40,000 | |
Jun 13 2008 | ILIU | INTERLEUKIN GENETI ... | PYXIS INNOVATIONS INC | 10% Owner | Buy | C | 0.64 | 943,032 | 602,786 | 6,884,057 | 5.9 M to 6.9 M (+15.87 %) |
May 02 2008 | ILIU | INTERLEUKIN GENETI ... | KORNMAN KENNETH S | President & CSO | Grant | A | 1.50 | 12,500 | 18,750 | 98,750 | 86.3 K to 98.8 K (+14.49 %) |
Feb 20 2008 | ILIU | INTERLEUKIN GENETI ... | BENDER LEWIS H | Chief Executive Off ... | Buy | P | 1.40 | 3,000 | 4,200 | 3,000 | 0 to 3 K |
Jan 29 2008 | ILIU | INTERLEUKIN GENETI ... | BENDER LEWIS H | Chief Executive Off ... | Option Exercise | A | 1.06 | 500,000 | 530,000 | 500,000 | |
Dec 19 2007 | ILIU | INTERLEUKIN GENETI ... | PYXIS INNOVATIONS INC | 10% Owner | Buy | C | 0.64 | 3,190,988 | 2,039,680 | 5,941,025 | 2.8 M to 5.9 M (+116.03 %) |
Apr 09 2007 | ILIU | INTERLEUKIN GENETI ... | KORNMAN KENNETH S | Chief Scientific Of ... | Grant | A | 4.38 | 12,500 | 54,750 | 86,250 | 73.8 K to 86.3 K (+16.95 %) |
Jan 18 2007 | ILIU | INTERLEUKIN GENETI ... | GAROFALO STEPHEN A | 10% Owner | Buy | P | 5.50 | 43,801 | 240,906 | 3,233,467 | 3.2 M to 3.2 M (+1.37 %) |
Jan 18 2007 | ILIU | INTERLEUKIN GENETI ... | GAROFALO STEPHEN A | 10% Owner | Buy | P | 5.50 | 1,369 | 7,530 | 3,189,666 | 3.2 M to 3.2 M (+0.04 %) |
Jan 18 2007 | ILIU | INTERLEUKIN GENETI ... | GAROFALO STEPHEN A | 10% Owner | Buy | P | 5.50 | 4,830 | 26,565 | 3,188,297 | 3.2 M to 3.2 M (+0.15 %) |
Dec 27 2006 | ILIU | INTERLEUKIN GENETI ... | KORNMAN KENNETH S | Chief Scientific Of ... | Option Exercise | M | 2.04 | 10,000 | 20,400 | 0 | |
Dec 27 2006 | ILIU | INTERLEUKIN GENETI ... | KORNMAN KENNETH S | Chief Scientific Of ... | Buy | M | 2.04 | 10,000 | 20,400 | 73,750 | 63.8 K to 73.8 K (+15.69 %) |
Dec 27 2006 | ILIU | INTERLEUKIN GENETI ... | KORNMAN KENNETH S | Chief Scientific Of ... | Gift | G | 6.32 | 3,500 | 22,120 | 63,750 | 67.3 K to 63.8 K (-5.20 %) |
Dec 27 2006 | ILIU | INTERLEUKIN GENETI ... | KORNMAN KENNETH S | Chief Scientific Of ... | Gift | G | 5.38 | 200 | 1,076 | 67,250 | 67.5 K to 67.3 K (-0.30 %) |